Status
Not open for further replies.

FeedBot

Staff member
Puma commences Phase II trial of alisertib for breast cancer treatment ... Puma Biotechnology has commenced the Phase II trial, ALISCA-Breast1, to ...

Continue reading...
 
Status
Not open for further replies.
Back
Top Bottom